CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $36.24, but opened at $33.91. CochLear shares last traded at $33.94, with a volume of 1,330 shares changing hands.
Analyst Ratings Changes
CHEOY has been the topic of several research reports. Zacks Research upgraded shares of CochLear to a “hold” rating in a research note on Friday, April 17th. UBS Group downgraded CochLear from a “strong-buy” rating to a “hold” rating in a research note on Thursday, April 23rd. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and three have given a Hold rating to the company. According to MarketBeat, CochLear currently has an average rating of “Moderate Buy”.
Read Our Latest Analysis on CochLear
CochLear Price Performance
CochLear Company Profile
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
See Also
- Five stocks we like better than CochLear
- Microsoft Build 2026 Is Really Just One Big AI Stress Test
- Slice of the Pie: Why Yum’s Deal Lifts QSR
- 3 Most Upgraded Stocks Last Month According to MarketBeat
- MongoDB Is the Latest SaaS Apocalypse Victim to Say “Not Today”
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
